GGrantIndex
← Leaderboards

Tony Tung Huang

New York University School Of Medicine

$10,994,698
Attributed
$10,994,698
Total exposure
7
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $3.2M · FY200925
$5M$3.8M$2.5M$1.3M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$14,782,654 · 8

By mechanism

R01$8,046,734 · 4
P01$4,617,170 · 3
R35$2,118,750 · 1

Top collaborators

Most similar at New York University School Of Medicine

Same institution · by research overlap

Others in their field

Top investigators on “Pathway Interactions

Research focus

Pathway InteractionsGenomic InstabilityCellsResponseMolecularRegulationDna DamageMalignant NeoplasmsPlayDna RepairGenomeGenome StabilityProgramsMaintenanceTumorigenesisDna BiosynthesisProteinsBaseCancer TherapyMutantSignal TransductionEventEquilibriumMediating

Grant awards (34)

Investigating and Targeting Replication Stress in Small Cell Lung Cancer$1,893,978
P01 · FY2025 · CA · contact PI
Understanding the mechanistic role of genome stability pathways in regulating cell homeostasis$423,750
R35 · FY2025 · GM · contact PI
Defining the molecular basis of oncogene-induced replication stress$419,343
R01 · FY2025 · ES · contact PI
Mechanisms of Replication Stress Tolerance in SCLC$351,711
P01 · FY2025 · CA · contact PI
Administrative Core$62,896
P01 · FY2025 · CA · contact PI
Investigating and Targeting Replication Stress in Small Cell Lung Cancer$1,893,978
P01 · FY2024 · CA · contact PI
Defining the molecular basis of oncogene-induced replication stress$426,547
R01 · FY2024 · ES · contact PI
Understanding the mechanistic role of genome stability pathways in regulating cell homeostasis$423,750
R35 · FY2024 · GM · contact PI
Mechanisms of Replication Stress Tolerance in SCLC$351,711
P01 · FY2024 · CA · contact PI
Administrative Core$62,896
P01 · FY2024 · CA · contact PI
Defining the molecular basis of oncogene-induced replication stress$433,750
R01 · FY2023 · ES · contact PI
Understanding the mechanistic role of genome stability pathways in regulating cell homeostasis$423,750
R35 · FY2023 · GM · contact PI
Defining the molecular basis of oncogene-induced replication stress$440,954
R01 · FY2022 · ES · contact PI
Understanding the mechanistic role of genome stability pathways in regulating cell homeostasis$423,750
R35 · FY2022 · GM · contact PI
Defining the molecular basis of oncogene-induced replication stress$448,158
R01 · FY2021 · ES · contact PI
Understanding the mechanistic role of genome stability pathways in regulating cell homeostasis$423,750
R35 · FY2021 · GM · contact PI
Mechanisms of reversible DUB oxidation in genome stability pathways - Revision$354,319
R01 · FY2020 · ES · contact PI
Mechanisms of reversible DUB oxidation in genome stability pathways$381,375
R01 · FY2019 · ES · contact PI
Mechanisms of reversible DUB oxidation in genome stability pathways$381,375
R01 · FY2018 · ES · contact PI
Control of HSV-1 neuronal latency and growth by DNA repair choice$334,763
R01 · FY2018 · GM · contact PI
Mechanisms of reversible DUB oxidation in genome stability pathways$381,375
R01 · FY2017 · ES · contact PI
Control of HSV-1 neuronal latency and growth by DNA repair choice$334,763
R01 · FY2017 · GM · contact PI
Mechanisms of reversible DUB oxidation in genome stability pathways$381,375
R01 · FY2016 · ES · contact PI
Control of HSV-1 neuronal latency and growth by DNA repair choice$334,763
R01 · FY2016 · GM · contact PI
Mechanisms of reversible DUB oxidation in genome stability pathways$381,375
R01 · FY2015 · ES · contact PI
Control of HSV-1 neuronal latency and growth by DNA repair choice$334,763
R01 · FY2015 · GM · contact PI
Role of Deubiquitination in Fanconi Anemia Cancer Susceptibility Pathway$328,642
R01 · FY2013 · GM · contact PI
Role of Deubiquitination in Fanconi Anemia Cancer Susceptibility Pathway$294,321
R01 · FY2013 · GM · contact PI
Role of Deubiquitination in Fanconi Anemia Cancer Susceptibility Pathway$340,561
R01 · FY2012 · GM · contact PI
Role of Deubiquitination in Fanconi Anemia Cancer Susceptibility Pathway$340,561
R01 · FY2011 · GM · contact PI
Role of Deubiquitination in Fanconi Anemia Cancer Susceptibility Pathway$344,000
R01 · FY2010 · GM · contact PI
Role of Deubiquitination in Fanconi Anemia Cancer Susceptibility Pathway$69,912
R01 · FY2010 · GM · contact PI
Role of Deubiquitination in Fanconi Anemia Cancer Susceptibility Pathway$347,475
R01 · FY2009 · GM · contact PI
Role of Deubiquitination in Fanconi Anemia Cancer Susceptibility Pathway$212,264
R01 · FY2009 · GM · contact PI